MEDOXY
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
2024
31-12
Financial
Equity above €150,000equity €196,312 ▲44.1%
With a profit in every financial year since 2022, equity grows to €196,312.
2023
31-12
Financial
Highest result from 2022 to 2025net €102,958 ▲230%
The operating result of €129,861 and the net result of €102,958 are both a record.
31-12
Financial
Equity above €100,000equity €136,204 ▲310%
With a profit in every financial year since 2022, equity grows to €136,204.
15-08
micro format · 15 days late
2022
06-09
Gazette deed
IncorporationStarting capital €2,000 · Appointment: PIROTTE Kevin Jean-Marie René (director) · Founder12 points ▸
Gazette deed
Incorporation
Starting capital €2,000 · Appointment: PIROTTE Kevin Jean-Marie René (director) · Founder12 points ▸
- Incorporation, “MEDOXY” (deed in French)
- Founder, PIROTTE Kevin Jean-Marie René
- Founding capital, €2,000
- Other provision, 29-08-2022
- Other provision, “responsabilité des fondateurs en cas de faillite, trois ans de l’acquisition de la personnalité juridique” (deed in French)
- Declaration, “attestation de dépôt en espèces, conformément aux dispositions du Code des sociétés et des associations” (deed in French)
- Capital
- Other provision, “conformément à la loi, effectivité des décisions finales” (deed in French)
- Registered office clause, “4121 Neuville-en-Condroz,Rue des Bouvreuils 10” (deed in French)
- Board rule, 1
- Director appointment, PIROTTE Kevin Jean-Marie René (director (not named in the articles))
- Pre-incorporation commitments, “engagements pris par le comparant au nom de la société en formation, comparant reste personnellement tenu” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank